A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria
Status:
Terminated
Trial end date:
2009-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the study drug (antimalarial medication) is safe
when given to healthy subjects as a single dose or as repeated doses, to understand the
effect of food on single doses of study drug and to determine if the study drug has an effect
on other approved medications such as rosiglitazone and rosuvastatin.